Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
2.08
USD
|
+0.97%
|
|
+2.46%
|
-22.68%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
376.6
|
339.1
|
289.5
|
264.4
|
106.5
|
133.3
|
Enterprise Value (EV)
1 |
331.1
|
294
|
267.3
|
247.9
|
93.65
|
115.4
|
P/E ratio
|
-34
x
|
-247
x
|
-26.3
x
|
7.31
x
|
-16.1
x
|
5.58
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.54
x
|
1.35
x
|
1.21
x
|
1.06
x
|
0.46
x
|
0.55
x
|
EV / Revenue
|
1.36
x
|
1.17
x
|
1.12
x
|
0.99
x
|
0.4
x
|
0.48
x
|
EV / EBITDA
|
56
x
|
39.6
x
|
-299
x
|
35
x
|
-14.3
x
|
4.32
x
|
EV / FCF
|
8.95
x
|
465
x
|
-51.6
x
|
-7.59
x
|
-9.28
x
|
7.03
x
|
FCF Yield
|
11.2%
|
0.22%
|
-1.94%
|
-13.2%
|
-10.8%
|
14.2%
|
Price to Book
|
2.01
x
|
1.3
x
|
0.96
x
|
0.83
x
|
102
x
|
0.77
x
|
Nbr of stocks (in thousands)
|
50,082
|
50,231
|
50,520
|
49,789
|
50,005
|
49,553
|
Reference price
2 |
7.520
|
6.750
|
5.730
|
5.310
|
2.130
|
2.690
|
Announcement Date
|
3/26/19
|
3/11/20
|
3/10/21
|
3/11/22
|
3/10/23
|
3/14/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
244
|
250.5
|
238.9
|
250.5
|
232.5
|
240.7
|
EBITDA
1 |
5.911
|
7.422
|
-0.894
|
7.076
|
-6.531
|
26.69
|
EBIT
1 |
2.002
|
5.745
|
-2.317
|
5.936
|
-7.067
|
26.17
|
Operating Margin
|
0.82%
|
2.29%
|
-0.97%
|
2.37%
|
-3.04%
|
10.88%
|
Earnings before Tax (EBT)
1 |
2.002
|
5.745
|
-12.32
|
-6.688
|
-7.067
|
26.17
|
Net income
1 |
-11.06
|
-1.37
|
-10.99
|
36.79
|
-6.638
|
24.44
|
Net margin
|
-4.53%
|
-0.55%
|
-4.6%
|
14.68%
|
-2.85%
|
10.15%
|
EPS
2 |
-0.2209
|
-0.0273
|
-0.2180
|
0.7264
|
-0.1324
|
0.4822
|
Free Cash Flow
1 |
36.98
|
0.6326
|
-5.18
|
-32.66
|
-10.09
|
16.41
|
FCF margin
|
15.15%
|
0.25%
|
-2.17%
|
-13.04%
|
-4.34%
|
6.82%
|
FCF Conversion (EBITDA)
|
625.57%
|
8.52%
|
-
|
-
|
-
|
61.5%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
67.17%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/26/19
|
3/11/20
|
3/10/21
|
3/11/22
|
3/10/23
|
3/14/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
45.5
|
45.1
|
22.2
|
16.5
|
12.9
|
17.9
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
37
|
0.63
|
-5.18
|
-32.7
|
-10.1
|
16.4
|
ROE (net income / shareholders' equity)
|
-5.38%
|
-0.61%
|
-3.92%
|
11.8%
|
-4.13%
|
16.3%
|
ROA (Net income/ Total Assets)
|
0.08%
|
0.21%
|
-0.08%
|
0.2%
|
-0.26%
|
1%
|
Assets
1 |
-14,422
|
-641.4
|
13,616
|
18,338
|
2,574
|
2,435
|
Book Value Per Share
2 |
3.750
|
5.170
|
5.960
|
6.410
|
0.0200
|
3.470
|
Cash Flow per Share
2 |
0.9100
|
0.9200
|
0.6800
|
0.5500
|
0.4600
|
0.5400
|
Capex
1 |
0.72
|
0.51
|
0.22
|
1.01
|
0.1
|
0.44
|
Capex / Sales
|
0.3%
|
0.2%
|
0.09%
|
0.4%
|
0.04%
|
0.18%
|
Announcement Date
|
3/26/19
|
3/11/20
|
3/10/21
|
3/11/22
|
3/10/23
|
3/14/24
|
|
1st Jan change
|
Capi.
|
---|
| -22.68% | 103M | | +3.05% | 95.15B | | +1.78% | 94.71B | | -20.65% | 77.24B | | +18.68% | 74.93B | | +6.69% | 30.04B | | +18.06% | 27.87B | | +4.32% | 26.97B | | -1.21% | 16.99B | | -9.10% | 15.16B |
Life Insurance
|